Janus Henderson Group PLC Dyne Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 6,813,163 shares of DYN stock, worth $163 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
6,813,163
Previous 4,623,824 47.35%
Holding current value
$163 Million
Previous $163 Million 49.98%
% of portfolio
0.13%
Previous 0.09%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$31.94 - $47.04 $69.9 Million - $103 Million
2,189,339 Added 47.35%
6,813,163 $245 Million
Q2 2024

Aug 14, 2024
BUY
$23.65 - $35.63 $46.1 Million - $69.4 Million
1,948,584 Added 72.84%
4,623,824 $163 Million
Q1 2024

May 15, 2024
BUY
$13.06 - $29.18 $34.8 Million - $77.7 Million
2,663,910 Added 23512.0%
2,675,240 $76 Million
Q4 2023

Feb 14, 2024
SELL
$6.62 - $13.64 $225 - $463
-34 Reduced 0.3%
11,330 $150,000
Q3 2023

Nov 14, 2023
BUY
$8.6 - $12.18 $120 - $170
14 Added 0.12%
11,364 $101,000
Q2 2023

Aug 14, 2023
BUY
$8.53 - $14.28 $93 - $157
11 Added 0.1%
11,350 $127,000
Q1 2023

May 15, 2023
BUY
$10.88 - $15.0 $123,368 - $170,085
11,339 New
11,339 $130,000
Q3 2022

Nov 14, 2022
SELL
$7.2 - $15.17 $2.12 Million - $4.47 Million
-294,348 Reduced 27.76%
765,953 $9.73 Million
Q2 2022

Aug 15, 2022
SELL
$4.36 - $10.5 $533,685 - $1.29 Million
-122,405 Reduced 10.35%
1,060,301 $7.29 Million
Q1 2022

May 16, 2022
BUY
$6.52 - $12.27 $3.91 Million - $7.37 Million
600,408 Added 103.11%
1,182,706 $11.4 Million
Q4 2021

Feb 14, 2022
BUY
$11.89 - $16.07 $283,160 - $382,707
23,815 Added 4.26%
582,298 $6.92 Million
Q3 2021

Nov 16, 2021
SELL
$15.6 - $21.46 $135,454 - $186,337
-8,683 Reduced 1.53%
558,483 $9.07 Million
Q2 2021

Aug 16, 2021
SELL
$15.94 - $22.33 $4.73 Million - $6.63 Million
-296,908 Reduced 34.36%
567,166 $11.9 Million
Q1 2021

May 17, 2021
BUY
$14.0 - $29.3 $3.28 Million - $6.86 Million
234,222 Added 37.19%
864,074 $13.4 Million
Q4 2020

Feb 16, 2021
SELL
$16.81 - $23.94 $5.99 Million - $8.53 Million
-356,111 Reduced 36.12%
629,852 $13.2 Million
Q3 2020

Nov 16, 2020
BUY
$20.0 - $23.9 $19.7 Million - $23.6 Million
985,963 New
985,963 $19.9 Million

Others Institutions Holding DYN

# of Institutions
209
Shares Held
102M
Call Options Held
234K
Put Options Held
238K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email